US20080108971A1 - Infiltration cannula - Google Patents
Infiltration cannula Download PDFInfo
- Publication number
- US20080108971A1 US20080108971A1 US12/004,778 US477807A US2008108971A1 US 20080108971 A1 US20080108971 A1 US 20080108971A1 US 477807 A US477807 A US 477807A US 2008108971 A1 US2008108971 A1 US 2008108971A1
- Authority
- US
- United States
- Prior art keywords
- cannula
- infiltration
- patient
- fluid
- flexible tubular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0097—Catheters; Hollow probes characterised by the hub
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
- A61M5/3291—Shafts with additional lateral openings
Definitions
- the tumescent technique is a method of subcutaneous drug delivery of large volumes of very dilute medication together with dilute epinephrine in isotonic solution of crystalloid infiltrated directly into subcutaneous fat or muscle to produce swelling and firmness, or tumescence, of the targeted tissues, and thus produce very slow systemic absorption as a result of intense subcutaneous vasoconstriction.
- Tumescent drug delivery refers to the tumescent technique for delivering a drug into the subcutaneous space. Drugs other than lidocaine can be administered by means of tumescent delivery, that is, by subcutaneous infiltration of extremely dilute drug, with or without epinephrine as a vasoconstrictor.
- Tumescent Local Anesthesia is local anesthesia produced by direct infiltration into subcutaneous tissue of large volumes of very dilute lidocaine and epinephrine in a crystaloid solution such as physiologic saline (NaCl) or lactated Ringer's solution.
- Tumescent Local Anesthetic Solution is the local anesthetic solution used to produce TLA.
- a TLA Solution consists of a 10 to 20 fold dilution of commercially available concentration of lidocaine and epinephrine.
- a commercial solution of lidocaine and epinephrine contains 10 grams of lidocaine per liter (10 gm/L) and 10 milligrams of epinephrine per liter.
- TLA Solution typically contains less than 1 gm/L lidocaine and epinephrine (1 mg/L).
- the volume of infiltrated TLA Solution is so large that the skin and subcutaneous tissue becomes tumescent, in other words swollen and firm.
- the present invention relates in general to cannulas and in particular to an infiltration cannula that allows for intermittent infiltration of fluids, such as a local anesthetic.
- Infiltrators are known as sprinkler-tip or KleinTM (the present applicant) needle infiltrators.
- These cannulas are constructed out of a rigid stainless steel and have one or more apertures, which are typically round or oval, and are distributed about the distal end of the cannula. The apertures are distributed over about 15% to 25% or less than 5.0 cm. of the distal end of the cannula needle.
- infiltration cannulas are intended to be inserted through a small incision in the patient's skin and then moved in and out through the subcutaneous tissue while a dilute solution of local anesthetic (or other pharmaceutical solution) is ejected through the distal apertures.
- Such infiltrators typically have a blunt tip and require the placement of a small hole (made by a one mm skin-biopsy punch or a small surgical blade) through which the blunt tipped cannula can be passed.
- the piston-like in and out motion of the cannula causes the patient discomfort.
- PICC line a peripherally inserted central catheter
- IV intravenous
- the On-Q® Pain Management System marketed by I-Flow® Corporation employs a PICC line type system for continuously providing local anesthetic.
- This system provides prolonged local anesthesia by means of an elastomer (elastic container) device that continuously infiltrates a solution of local anesthesia over many hours.
- the On-Q® device comprises a long soft flexible tube with many small holes arranged along a significant portion of the tube.
- the On-Q® device is designed to be initially positioned within a surgical wound at the time of surgery. After the surgical wound is closed, the On-Q® device permits slow steady infiltration of a local anesthetic solution into the wound, thereby attenuating post-operative pain.
- the On-Q® device cannot be inserted through a tiny hole in the skin into subcutaneous tissue.
- Another example is the need to provide emergency fluid resuscitation to large numbers of patients in acute epidemic diarrhea (dehydration) associated with biological warfare, or mass-trauma situations such as a natural disaster (earth quake) or terrorist attack.
- a device that can easily provide localized fluid resuscitation to burn victims whereby fluid is infiltrated into the subcutaneous tissue directly subjacent to burned skin.
- the present invention comprises an infiltration cannula and method of using the infiltration cannula during an infiltration procedure.
- the infiltration cannula preferably includes: a flexible cannula, a hub, and a rigid stylet.
- the flexible cannula has a proximal end and a distal end.
- the flexible cannula also has a plurality of apertures disposed in a pattern about the distal end. The apertures are configured to infiltrate fluid into the subcutaneous tissue of a patient.
- the hub is configured to be held by a person performing the infiltration procedure.
- the hub has a first end and an opposing second end.
- the first end is attached to the proximal end of the flexible cannula and the second end includes a connector configured to connect to an input source for receiving the fluid to be infiltrated into the subcutaneous tissue of the patient.
- the fluid flows from the connector, through the hub and into the flexible cannula.
- the flexile cannula may be manufactured of plastic and the rigid stylet may be fabricated from stainless metal or rigid plastic.
- the distal end of the cannula is closed to cover the tip of the rigid stylet or open with a hole allowing the tip of the rigid stylet to protrude through.
- the tip of the rigid stylet is either sharp to directly insert through the skin of the patient, or so blunt that a skin incision is required to permit insertion of the rigid stylet and the cannula into the subcutaneous space.
- the stylet may be formed to have either a solid or hollow cross-sectional configuration.
- the apertures may be arranged in a helical pattern or in a spiral pattern.
- the apertures may be distributed over about 33% to about 90% of the distal end of the tubular needle.
- the apertures may be round or oval.
- the size of the apertures need not necessarily be equal.
- the fluid may comprise a local anesthetic or any other therapeutic solution.
- the infiltration procedure may be performed in conjunction with conventional medical procedures such as liposuction, but additionally may simply be used as a mode of systemic drug delivery, or systemic fluid replacement therapy.
- a method of infiltrating fluid into subcutaneous tissue of a patient using an infiltration cannula may include the following steps.
- a rigid stylet is inserted through a flexible infiltration cannula.
- the infiltration cannula is inserted through a patient's skin and into the subcutaneous tissue or muscle tissue of the patient at a desired site with the stylet serving as a guiding wire.
- a fluid is provided from a fluid source via the connector.
- the fluid is transported from the connector through the hub and into the flexible cannula.
- the fluid is ejected from the cannula into the subcutaneous tissue or muscle of the patient via the apertures.
- the infiltration cannula used in performing the method preferably includes a connector for receiving the fluid from a fluid source, a hub in communication with the connector and a flexible cannula in communication with the hub.
- the tubular needle has a plurality of apertures disposed in a pattern about a distal end. The apertures are configured to infiltrate the fluid into the subcutaneous tissue or muscle of the patient.
- the above steps may be repeated intermittently, at intervals between a few minutes to many hours.
- the infiltration cannula may be removed or may remain in place for possible additional infiltration.
- the infiltration cannula may additionally be inserted at a new site.
- Multiple infiltration cannulas may be used simultaneously. Use of multiple infiltration cannulas prevents disruption of the infiltration process when one infiltration cannula is removed. Multiple infiltrators can be simultaneously inserted into separate areas to facilitate more rapid delivery of fluids.
- FIG. 1 is a side elevation view of a stainless steel infiltration cannula with a closed tip shown inserted in subcutaneous tissue shown in partial cross section;
- FIG. 2 is a section view of the infiltration cannula shown in FIG. 1 ;
- FIG. 3 is a side elevation view of a plastic infiltration cannula with a closed tip shown inserted in subcutaneous tissue shown in partial cross section;
- FIG. 4 is an exploded view of the infiltration cannula shown in FIG. 3 ;
- FIG. 5 is a flow diagram illustrating an exemplary procedure for using an infiltration cannula such as the one shown in FIG. 1 or the one shown in FIG. 3 ;
- FIG. 6 is an exploded side elevation view of a plastic infiltration cannula through which a blunt-tipped stylet can be inserted;
- FIG. 7 is a side view of a sharp-tipped stylet insertable through the plastic infiltration cannula of FIG. 6 .
- the present invention takes advantage of the tumescent technique in order to provide intermittent or continuous, brief or prolonged infiltration of local anesthetic, physiologic fluid, antibiotics or other therapeutic solution.
- the present invention results in a significant decrease in patient discomfort due to the elimination of the piston-like in and out motion of the cannula. Once the cannula is positioned in place, there is no need to repeatedly move the cannula in and out through the tissue in order to deliver the fluid to a wide area.
- the time needed in order to complete the infiltration of a targeted anatomic area is reduced to nearly half of the time required when using traditional prior art cannulas.
- the device and method of the present invention can use multiple (e.g., two or more) infiltration cannulas simultaneously. While one cannula is actively dispersing tumescent fluid into the subcutaneous tissue, the surgeon can reposition a second infiltration cannula. This allows the infiltration process to proceed without interruption, whereas prior art techniques of infiltration must be ceased each time the cannula is withdrawn from the skin and re-inserted into another direction.
- the flexible cannula version of the present invention provides a means for relatively rapid fluid resuscitation in emergency situations such as when establishing an intravenous (IV) access is not feasible.
- the flexible cannula may have important applications as in treating a wounded soldier in night-time combat conditions when establishing an IV access in total darkness is nearly impossible or using a flash light might attract enemy fire.
- the flexible cannula may similarly have important applications in other areas of use such as treating mass-casualty victims suffering hypovolemia as a result of epidemic infections, biologic warfare, or trauma such as explosions, burns or radiation exposure.
- the flexible cannula similarly has applications in surgical patients wherein the surgeon can provide localized pre-operative preemptive analgesia and simultaneously provide tumescent delivery of a prophylactic dose of an antibiotic aimed precisely at tissues targeted for surgical intervention.
- the tumescent technique comprises a drug delivery system that takes advantage of a recently discovered reservoir effect of injecting a relatively large volume of relatively dilute solution of a drug into the subcutaneous tissue.
- the present invention takes advantage of the tumescent reservoir phenomenon for one of its important applications. After a large volume of fluid containing dilute epinephrine is injected into subcutaneous tissue, the epinephrine-induced vasoconstriction dramatically slows the systemic absorption of the fluid. In effect, this large volume of subcutaneous fluid behaves in a fashion that is analogous to the behavior of a slow-release tablet in the stomach after oral ingestion.
- the drug is isolated from the systemic circulation by the fact that only the drug on the outer boundary of the mass of drug is the available for absorption, whereas the portion of the drug located within the central portion of the mass of fluid is virtually isolated from the systemic circulation by virtue of profound capillary vasoconstriction.
- the tumescent fluid does not contain epinephrine there is no clinically significant vasoconstriction after tumescent infiltration, and the tumescent fluid is absorbed relatively rapidly. This has important clinical applications in situations where patients are hypovolemic or dehydrated and unable to be given fluids by mouth or intravenously.
- the tumescent technique permits rapid systemic hydration by direct subcutaneous or intramuscular injection of a large volume of fluid through a multi-fenestrated infiltration cannula described in this invention.
- hypodermoclysis There is a prior art technique known as hypodermoclysis wherein a fluid is slowly and continuously infiltrated subcutaneously using a type of steel hypodermic needle, known as a butterfly needle, having a single distal aperture in order to provide fluid to patients who cannot be given fluids by mouth and for whom an IV access cannot be established.
- a type of steel hypodermic needle known as a butterfly needle
- hypodermoclysis is used in the treatment of infants, or cancer patients, in which IV access is not easily achieved.
- the technique of hypodermoclysis is typically used to deliver relatively small volumes of fluid, for example an adult might receive 70 ml per hour. At this small hourly volume hypodermoclysis is not an efficient method for the rapid systemic delivery of fluid in emergency situations that might require two to four liters per hour.
- the local interstitial fluid pressure increases rapidly immediately adjacent to the single aperture as fluid infiltrates locally, which in turn dramatically slows the rate of subsequent fluid flow into the area.
- the multiple apertures formed along the length of the cannula as described in the present invention distribute the fluid throughout a much larger volume tissue before there can be a sufficient increase in the interstitial fluid to decrease the rate of additional infiltration.
- a preferred suitable peristaltic infiltration pump is described in pending U.S. patent application Ser. No. 10/811,733, filed Mar. 29, 2004, entitled INFILTRATION PUMP HAVING INSULATED ROLLERS AND PROGRAMMABLE FOOT PEDAL, the disclosure of which is expressly incorporated herein by reference.
- the peristaltic pump provides a sufficient degree of pressure to easily overcome the localized increased interstitial pressure associated with the local effects of a tumescent infiltration.
- the present invention still permits relatively rapid tumescent infiltration by virtue of the multiple holes distributed along the length of the flexible cannula.
- external hydrostatic pressure can be applied to the fluid flowing into the flexible cannula from the fluid reservoir by means of gravitational force derived from elevating the reservoir one to two meters above the patient.
- the infiltration process can be continuous or intermittent.
- the intermittent injections are administered at intervals ranging from every few minutes to eight to twelve hours or more.
- FIGS. 1 and 2 illustrate a stainless steel (reusable) infiltration cannula 10
- FIGS. 3-4 and 6 - 7 illustrate a (single use) plastic infiltration cannula 30 .
- the cannula 10 , 30 can be inserted under the skin 52 and into the subcutaneous tissue 50 and tumescent local anesthesia can be infiltrated once every eight to twelve hours.
- Stainless steel infiltration cannulas 10 are formed having precision high quality and are preferably reusable. These cannulas can be used to provide tumescent local anesthesia for surgical procedures, such as liposuction, which require tumescent local anesthesia over a relatively large area.
- the cannula 10 includes a tubular needle portion 12 which has a proximal end 14 and a distal end 16 .
- the proximal end 14 of the tubular needle 12 is attached to a hub 20 that is used by the anesthesiologist or surgeon to grasp and hold the cannula 10 during the infiltration procedure.
- the hub 20 is connected to the tubular needle 12 at a first end 22 and has a connector 24 , such as a luer lock, at an opposing second end.
- the connector 24 is connected to a fluid source, such as tubing connected to an IV bag. Fluid enters the cannula 10 via the connector 24 .
- the tip at the distal end 16 is closed.
- the local anesthetic is infiltrated into the patient via apertures 18 located proximate the distal end 16 of the tubular needle 12 of the cannula 10 .
- the apertures 18 are disposed along the distal end 16 of the cannula 10 in a spiral or helical pattern and are distributed over the distal 33% to 90% of the tubular needle 12 of the cannula 10 .
- the pattern of apertures of the cannula 10 are preferably distributed over 33% of the tubular needle 12 of the cannula 10 .
- the proximal portion 14 of the cannula 10 is preferably devoid of apertures in order to prevent fluid from leaking out of the cannula insertion site in the skin.
- Flexible plastic infiltration cannulas 30 are single use cannulas and can be used in one of several unique ways.
- an anesthesiologist or surgeon can insert an infiltration cannula 30 with stylet 46 into the subcutaneous tissue 50 , remove the stylet 46 , then attach an IV tubing to the infiltrator and inject tumescent local anesthesia into the targeted area without subsequent repositioning of the infiltration cannula 30 .
- the plastic flexible nature of the infiltration cannula 32 of the disposable plastic cannula 30 allows the patient to move or change position of the body without risk of injury that might result if a patient moves while a rigid steel cannula is inserted.
- the stylet 46 is formed of metal, e.g., stainless steel, or of a rigid plastic material.
- the plastic cannula 30 can be blunt-tipped with the metal stylet tip 48 covered by the rounded tip 39 of the plastic cannula 30 .
- the plastic cannula 30 can be open-ended with the stylet 46 extending a short distance past the end 39 of the plastic cannula 30 as shown in FIG. 6 .
- the stylet 46 can be either blunt-tipped (see FIG. 6 ; requiring a skin incision to permit insertion into the subcutaneous space), or sharp-tipped (see FIG. 7 ; permitting the cannula to be inserted directly through the skin and into the subcutaneous space or muscle without requiring a preparatory skin incision).
- the sharp-tipped stylet can be formed in either a solid or hollow cross-sectional configuration.
- the plastic cannula shown in FIGS. 3 and 4 is similar to an IV catheter except the sharp hollow stylet used for the insertion of an IV catheter can be replaced by a solid obturator/stylet 46 that can be either sharp or blunt tipped. Except for the removable stylet 46 , the plastic cannula 30 is similar to the stainless steel cannula 10 shown in FIGS. 1 and 2 and described above.
- the plastic cannula 30 includes a flexible tubular needle 32 having a proximal end 34 and a distal end 36 . The distal end has apertures 38 and the proximal end 34 is devoid of apertures.
- the pattern of apertures 38 in the cannula 30 are distributed over the distal 33% to 90% of the tubular needle 32 of the cannula 30 .
- the tubular needle 32 of cannula 30 shown in FIGS. 3 and 4 has a length D of 15 cm and the pattern of apertures are distributed over a length d 1 of 13.5 cm, then the apertures 38 are distributed over 90% of the cannula.
- a typical infiltration cannula 10 , 30 may have a diameter equivalent to 20, 18, 16 or 14 gauge with small apertures 18 , 38 placed every 5 mm along the cannula in a spiral or helical pattern. It will be appreciated that the dimensions used herein are exemplary and that the cannula dimensions, range of gauge, length of cannula, relative size shape and pattern of apertures can vary greatly depending upon clinical preference.
- the proximal end 34 of the tubular needle 32 shown in FIGS. 3 and 4 is attached to a hub 40 that is used by the anesthesiologist or surgeon to hold the cannula 30 during the infiltration procedure.
- the hub 40 is connected to the tubular needle 32 at a first end 42 and has a connector 44 at an opposing second end.
- the connector 44 is connected to a fluid source.
- the stylet 46 can be inserted and removed from the cannula 30 .
- Infiltration using a plastic infiltration cannula 30 can be accomplished using an infiltration pump.
- the force of gravity could be used to push the tumescent fluid into the tissues by hanging a reservoir plastic bag of tumescent local anesthesia (or other dilute drug, such as a chemotherapeutic agent or antibiotics) on an IV pole and connecting bag to the infiltration cannula by an IV line.
- Another application is the injection of tumescent local anesthesia into a localized area through which a surgeon plans to make a surgical incision.
- the effects of vasoconstriction, resulting from the epinephrine in the tumescent local anesthetic solution, within the tumesced tissue minimizes surgical bleeding.
- the present invention can produce, via the pre-operative infiltration of tumescent local anesthesia, prolonged post operative analgesia and also preemptively reduce the risk of surgical wound infections resulting from the bacteriacidal effects of lidocaine.
- Yet another application is to provide an easily accessible route for systemic administration of crystalloid fluids/electrolytes for systemic hydration or for other types of drug therapy.
- Potential clinical applications include emergency resuscitation with systemic fluids in situations where insertion of an IV catheter into a vein cannot be readily achieved. Examples of situations where emergency access for intravenous delivery of fluids might not be possible include acute trauma or burn wound in civilian or military situations.
- Another application may be the emergency treatment of dehydration associated with prolonged vomiting or diarrhea as a result of chemical warfare or biological warfare (e.g., epidemic cholera among pediatric patients in rural third world settings).
- a subcutaneous infiltration catheter can easily be introduced by a layman, whereas inserting an IV catheter into a vein of a patient that is severely dehydrated can be difficult even for a skilled physician. Delivery of systemic fluids by subcutaneous infiltration is safer in a zero gravity situation (for example, the Space Station).
- the addition of a small amount of capillary vasodilator (e.g., methylnicotinamide) to the subcutaneous fluid can be used to accelerate the systemic absorption of the fluid or drug into the intravascular space.
- the cannula 10 , 30 is intended to be inserted far enough through the skin 52 so that all of the apertures 18 , 38 are within the fat 50 or muscle of the patient. Once the cannula 10 , 30 is properly positioned, it can remain stationary while the local anesthetic (or other pharmaceutical) solution is injected.
- the infiltration is briefly terminated (either by turning off the pump or by clamping the IV tubing) while the cannula 10 , 30 is repositioned into another area of the subcutaneous tissue.
- the infiltration is then restarted with the cannula stationary in its new position.
- the infiltrator 10 , 30 can also be used in the traditional mode whereby the cannula 10 , 30 is moved through the targeted tissue while the fluid is simultaneously pumped through the cannula 10 , 30 and into the subcutaneous tissue 50 .
- tumescent technique's reservoir effect Another unique aspect of the tumescent technique's reservoir effect is that one can conveniently achieve a long, slow, steady absorption of a drug delivered to the subcutaneous space 50 using periodic injections of a tumescent solution.
- the alternative technique can achieve a slow systemic absorption of a drug but may be difficult, require greater clinical expertise, be more expensive, and therefore, less practical than the technique described herein.
- FIG. 5 is a flow diagram illustrating steps performed in an exemplary infiltration procedure using a cannula 10 , 30 such as the one shown in FIGS. 1 and 2 or the one shown in FIGS. 3 and 4 , respectively.
- the procedure begins by inserting the tubular needle 12 , 32 of the infiltration cannula 10 , 30 into a desired subcutaneous tissue site 50 , e.g., via an incision in the patient's skin 52 (block 100 ). Fluid is then transported from the fluid source (e.g., an IV bag) into the cannula 10 , 30 via the connector 24 , 44 that is connected to the fluid source.
- the fluid source e.g., an IV bag
- the fluid is transported from the connector 24 , 44 through the hub 20 , 40 and into the tubular needle 12 , 32 (block 102 ).
- the fluid is then ejected from the cannula 10 , 30 into the subcutaneous tissue 50 of the patient via the apertures 18 , 38 at the distal end 16 , 36 of the tubular needle 12 , 34 of the cannula 10 , 30 (block 104 ).
- the fluid is transported (block 102 ) and ejected (block 104 ) until infiltration at the current site is completed (yes in decision block 106 ).
- the fluid can be injected into multiple sites in order to distribute the solution over a greater area.
- Infiltration at a particular site may be deemed complete upon emptying of the fluid source or based on the anesthesiologist or surgeon's decision to stop the infiltration at the current site.
- the infiltration can be briefly terminated (either by turning off the pump or by clamping the IV tubing) while the cannula 10 , 30 is repositioned into another area of the subcutaneous tissue.
- the infiltration may then be restarted with the cannula stationary in its new position. If the infiltration at a site is complete (yes in decision block 106 ), the cannula is removed from the current site (block 108 ).
- fluid is transported from the fluid source (block 102 ) and ejected into the subcutaneous tissue (block 104 ) until infiltration at the site is complete (yes in decision block 106 ).
- the tubular needle 12 , 32 of the infiltration cannula 10 , 30 is inserted into a new area of subcutaneous tissue 50 .
- the process described above is performed until the infiltration process is complete (yes in decision block 110 ). This process can be continuous or repeated intermittently.
- infiltration cannulas e.g., can be used at once.
- a second or additional cannulas can be inserted (block 100 ) at the same time as a first cannula is being removed (block 108 ).
- the infiltration process need not be interrupted in order to reposition a single cannula.
Abstract
An infiltration cannula and method of using the infiltration cannula during an infiltration procedure are disclosed herein. The infiltration cannula has a flexible cannula and a hub. The cannula has a proximal end and a distal end. The cannula also has a plurality of apertures disposed in a pattern about the distal end. The apertures are configured to infiltrate fluid into the subcutaneous or muscle tissue of a patient. The hub is configured to be held by a person performing the infiltration procedure. The hub has a first end and an opposing second end. The first end is attached to the proximal end of the flexible cannula and the second end includes a connector configured to connect to an input source for receiving the fluid to be infiltrated into the subcutaneous tissue of the patient. The fluid flows from the connector, through the hub and into the cannula.
Description
- The present application is a divisional application of U.S. application Ser. No. 10/877,566, filed on Jun. 25, 2004 which is a continuation-in-part application of U.S. patent application Ser. No. 10/442,370, filed on May 21, 2003 and is related to pending application Ser. No. 10/877,337, filed on Jun. 25, 2004, the disclosures of which are expressly incorporated herein by reference.
- Not Applicable
- Tumescent Technique The tumescent technique is a method of subcutaneous drug delivery of large volumes of very dilute medication together with dilute epinephrine in isotonic solution of crystalloid infiltrated directly into subcutaneous fat or muscle to produce swelling and firmness, or tumescence, of the targeted tissues, and thus produce very slow systemic absorption as a result of intense subcutaneous vasoconstriction.
- Tumescent Drug Delivery: Tumescent drug delivery refers to the tumescent technique for delivering a drug into the subcutaneous space. Drugs other than lidocaine can be administered by means of tumescent delivery, that is, by subcutaneous infiltration of extremely dilute drug, with or without epinephrine as a vasoconstrictor.
- Tumescent Local Anesthesia (TLA) is local anesthesia produced by direct infiltration into subcutaneous tissue of large volumes of very dilute lidocaine and epinephrine in a crystaloid solution such as physiologic saline (NaCl) or lactated Ringer's solution.
- Tumescent Local Anesthetic Solution (TLA Solution) is the local anesthetic solution used to produce TLA. Typically, a TLA Solution consists of a 10 to 20 fold dilution of commercially available concentration of lidocaine and epinephrine. Thus, a commercial solution of lidocaine and epinephrine contains 10 grams of lidocaine per liter (10 gm/L) and 10 milligrams of epinephrine per liter. In contrast TLA Solution typically contains less than 1 gm/L lidocaine and epinephrine (1 mg/L). Typically the volume of infiltrated TLA Solution is so large that the skin and subcutaneous tissue becomes tumescent, in other words swollen and firm.
- The present invention relates in general to cannulas and in particular to an infiltration cannula that allows for intermittent infiltration of fluids, such as a local anesthetic.
- Many medical procedures require infiltration of fluids, such as a local anesthetic. One method of infiltration of local anesthetic is via an infiltration cannula. Infiltrators are known as sprinkler-tip or Klein™ (the present applicant) needle infiltrators. These cannulas are constructed out of a rigid stainless steel and have one or more apertures, which are typically round or oval, and are distributed about the distal end of the cannula. The apertures are distributed over about 15% to 25% or less than 5.0 cm. of the distal end of the cannula needle. These traditional infiltration cannulas are intended to be inserted through a small incision in the patient's skin and then moved in and out through the subcutaneous tissue while a dilute solution of local anesthetic (or other pharmaceutical solution) is ejected through the distal apertures. Such infiltrators typically have a blunt tip and require the placement of a small hole (made by a one mm skin-biopsy punch or a small surgical blade) through which the blunt tipped cannula can be passed. The piston-like in and out motion of the cannula causes the patient discomfort.
- Another method of fluid insertion is via a peripherally inserted central catheter, also called a PICC line comprising an elongate plastic tube that is placed inside a vein of the patient. PICC lines are typically used for procedures requiring delivery of fluids over a prolonged period of time. For example, a PICC line may be used when a patient needs to receive intravenous (IV) fluids, such as medication or nutrients over a prolonged period of time, such as a week or more.
- The On-Q® Pain Management System marketed by I-Flow® Corporation employs a PICC line type system for continuously providing local anesthetic. This system provides prolonged local anesthesia by means of an elastomer (elastic container) device that continuously infiltrates a solution of local anesthesia over many hours. The On-Q® device comprises a long soft flexible tube with many small holes arranged along a significant portion of the tube. The On-Q® device is designed to be initially positioned within a surgical wound at the time of surgery. After the surgical wound is closed, the On-Q® device permits slow steady infiltration of a local anesthetic solution into the wound, thereby attenuating post-operative pain. The On-Q® device cannot be inserted through a tiny hole in the skin into subcutaneous tissue. Thus there is a need for a simple device that can permit the direct percutaneous insertion of a multi-holed infiltration cannula into subcutaneous tissue for the localized delivery of medications such as local anesthetics, chemotherapeutic agents, or crystalloids for parenteral hydration.
- Traditional techniques for subcutaneous injection of local anesthetic solutions use a high-concentration/low-volume of local anesthetic. This is associated with a rapid systemic absorption of the local anesthetic. In order to achieve a prolonged local anesthetic effect, the traditional techniques for using local anesthetics necessitate either frequent repeated injections or slow continuous subcutaneous infusion of the local anesthetic. As described above, repeated injections or piston-like movement of the cannula causes patient discomfort. Slow continuous infiltration may not be desirable in certain situations. Furthermore, continuous infiltrations restrict patient movement for extended periods of time which also cause the patient discomfort. Thus, there is a need for a system for infiltration of a local anesthetic into subcutaneous tissue which decreases patient discomfort, and allows prolonged local anesthesia either by rapid bolus injections or continuous slow infiltration. Furthermore there is a need for a devise that can provide pre-emptive local anesthesia before a surgical wound is created. There is also a need for a percutaneously-insertable infiltration cannula, with applications that are unrelated to the delivery of local anesthesia, which can be easily inserted by rescuers with minimal clinical skill or training. One example is the need for a cannula that permits emergency fluid resuscitation in situations where an IV cannot be established such as nighttime military combat conditions where using a flash light to establish an IV access would be extremely dangerous. Another example is the need to provide emergency fluid resuscitation to large numbers of patients in acute epidemic diarrhea (dehydration) associated with biological warfare, or mass-trauma situations such as a natural disaster (earth quake) or terrorist attack. There is also a need for a device that can easily provide localized fluid resuscitation to burn victims whereby fluid is infiltrated into the subcutaneous tissue directly subjacent to burned skin.
- The present invention comprises an infiltration cannula and method of using the infiltration cannula during an infiltration procedure. The infiltration cannula preferably includes: a flexible cannula, a hub, and a rigid stylet. The flexible cannula has a proximal end and a distal end. The flexible cannula also has a plurality of apertures disposed in a pattern about the distal end. The apertures are configured to infiltrate fluid into the subcutaneous tissue of a patient. The hub is configured to be held by a person performing the infiltration procedure. The hub has a first end and an opposing second end. The first end is attached to the proximal end of the flexible cannula and the second end includes a connector configured to connect to an input source for receiving the fluid to be infiltrated into the subcutaneous tissue of the patient. The fluid flows from the connector, through the hub and into the flexible cannula.
- The flexile cannula may be manufactured of plastic and the rigid stylet may be fabricated from stainless metal or rigid plastic. The distal end of the cannula is closed to cover the tip of the rigid stylet or open with a hole allowing the tip of the rigid stylet to protrude through. The tip of the rigid stylet is either sharp to directly insert through the skin of the patient, or so blunt that a skin incision is required to permit insertion of the rigid stylet and the cannula into the subcutaneous space. The stylet may be formed to have either a solid or hollow cross-sectional configuration.
- The apertures may be arranged in a helical pattern or in a spiral pattern.
- The apertures may be distributed over about 33% to about 90% of the distal end of the tubular needle.
- The apertures may be round or oval. The size of the apertures need not necessarily be equal.
- The fluid may comprise a local anesthetic or any other therapeutic solution.
- The infiltration procedure may be performed in conjunction with conventional medical procedures such as liposuction, but additionally may simply be used as a mode of systemic drug delivery, or systemic fluid replacement therapy.
- A method of infiltrating fluid into subcutaneous tissue of a patient using an infiltration cannula, such as the one described above may include the following steps.
- A rigid stylet is inserted through a flexible infiltration cannula. The infiltration cannula is inserted through a patient's skin and into the subcutaneous tissue or muscle tissue of the patient at a desired site with the stylet serving as a guiding wire. After the stylet let is withdrawn from the cannula, a fluid is provided from a fluid source via the connector. The fluid is transported from the connector through the hub and into the flexible cannula. The fluid is ejected from the cannula into the subcutaneous tissue or muscle of the patient via the apertures.
- The infiltration cannula used in performing the method preferably includes a connector for receiving the fluid from a fluid source, a hub in communication with the connector and a flexible cannula in communication with the hub. The tubular needle has a plurality of apertures disposed in a pattern about a distal end. The apertures are configured to infiltrate the fluid into the subcutaneous tissue or muscle of the patient.
- The above steps may be repeated intermittently, at intervals between a few minutes to many hours.
- After the desired amount of fluid has been infiltrated at a given site, the infiltration cannula may be removed or may remain in place for possible additional infiltration.
- The infiltration cannula may additionally be inserted at a new site.
- Multiple infiltration cannulas (e.g., two) may be used simultaneously. Use of multiple infiltration cannulas prevents disruption of the infiltration process when one infiltration cannula is removed. Multiple infiltrators can be simultaneously inserted into separate areas to facilitate more rapid delivery of fluids.
- These as well as other features of the present invention will become more apparent upon reference to the drawings wherein:
-
FIG. 1 is a side elevation view of a stainless steel infiltration cannula with a closed tip shown inserted in subcutaneous tissue shown in partial cross section; -
FIG. 2 is a section view of the infiltration cannula shown inFIG. 1 ; -
FIG. 3 is a side elevation view of a plastic infiltration cannula with a closed tip shown inserted in subcutaneous tissue shown in partial cross section; -
FIG. 4 is an exploded view of the infiltration cannula shown inFIG. 3 ; -
FIG. 5 is a flow diagram illustrating an exemplary procedure for using an infiltration cannula such as the one shown inFIG. 1 or the one shown inFIG. 3 ; -
FIG. 6 is an exploded side elevation view of a plastic infiltration cannula through which a blunt-tipped stylet can be inserted; and -
FIG. 7 is a side view of a sharp-tipped stylet insertable through the plastic infiltration cannula ofFIG. 6 . - As described in further detail below, the present invention takes advantage of the tumescent technique in order to provide intermittent or continuous, brief or prolonged infiltration of local anesthetic, physiologic fluid, antibiotics or other therapeutic solution. The present invention results in a significant decrease in patient discomfort due to the elimination of the piston-like in and out motion of the cannula. Once the cannula is positioned in place, there is no need to repeatedly move the cannula in and out through the tissue in order to deliver the fluid to a wide area. Using the tumescent technique and stainless steel versions of the present invention, the time needed in order to complete the infiltration of a targeted anatomic area is reduced to nearly half of the time required when using traditional prior art cannulas. The device and method of the present invention can use multiple (e.g., two or more) infiltration cannulas simultaneously. While one cannula is actively dispersing tumescent fluid into the subcutaneous tissue, the surgeon can reposition a second infiltration cannula. This allows the infiltration process to proceed without interruption, whereas prior art techniques of infiltration must be ceased each time the cannula is withdrawn from the skin and re-inserted into another direction.
- The flexible cannula version of the present invention provides a means for relatively rapid fluid resuscitation in emergency situations such as when establishing an intravenous (IV) access is not feasible. The flexible cannula may have important applications as in treating a wounded soldier in night-time combat conditions when establishing an IV access in total darkness is nearly impossible or using a flash light might attract enemy fire. The flexible cannula may similarly have important applications in other areas of use such as treating mass-casualty victims suffering hypovolemia as a result of epidemic infections, biologic warfare, or trauma such as explosions, burns or radiation exposure. The flexible cannula similarly has applications in surgical patients wherein the surgeon can provide localized pre-operative preemptive analgesia and simultaneously provide tumescent delivery of a prophylactic dose of an antibiotic aimed precisely at tissues targeted for surgical intervention.
- As is well known, the tumescent technique was discovered by Jeffrey Alan Klein, M.D. (the present applicant) in 1985. Dr. Klein first published a description of the tumescent technique in 1987 when he described the use of dilute lidocaine and epinephrine to permit liposuction totally by local anesthesia. The technique for tumescent local anesthesia is well known in dermatologic and plastic surgery literature. A detailed description of the tumescent technique has not been published in anesthesiology literature, and therefore, the unique benefits of the tumescent technique are not well recognized by anesthesiologists.
- The tumescent technique comprises a drug delivery system that takes advantage of a recently discovered reservoir effect of injecting a relatively large volume of relatively dilute solution of a drug into the subcutaneous tissue.
- The present invention takes advantage of the tumescent reservoir phenomenon for one of its important applications. After a large volume of fluid containing dilute epinephrine is injected into subcutaneous tissue, the epinephrine-induced vasoconstriction dramatically slows the systemic absorption of the fluid. In effect, this large volume of subcutaneous fluid behaves in a fashion that is analogous to the behavior of a slow-release tablet in the stomach after oral ingestion. Although there is a relatively large total amount of drug in the patients body, the drug is isolated from the systemic circulation by the fact that only the drug on the outer boundary of the mass of drug is the available for absorption, whereas the portion of the drug located within the central portion of the mass of fluid is virtually isolated from the systemic circulation by virtue of profound capillary vasoconstriction. In contrast, when the tumescent fluid does not contain epinephrine there is no clinically significant vasoconstriction after tumescent infiltration, and the tumescent fluid is absorbed relatively rapidly. This has important clinical applications in situations where patients are hypovolemic or dehydrated and unable to be given fluids by mouth or intravenously. The tumescent technique permits rapid systemic hydration by direct subcutaneous or intramuscular injection of a large volume of fluid through a multi-fenestrated infiltration cannula described in this invention.
- There is a prior art technique known as hypodermoclysis wherein a fluid is slowly and continuously infiltrated subcutaneously using a type of steel hypodermic needle, known as a butterfly needle, having a single distal aperture in order to provide fluid to patients who cannot be given fluids by mouth and for whom an IV access cannot be established. Typically hypodermoclysis is used in the treatment of infants, or cancer patients, in which IV access is not easily achieved. The technique of hypodermoclysis is typically used to deliver relatively small volumes of fluid, for example an adult might receive 70 ml per hour. At this small hourly volume hypodermoclysis is not an efficient method for the rapid systemic delivery of fluid in emergency situations that might require two to four liters per hour. The reason is that when using a cannula with only a single distal aperture, the local interstitial fluid pressure increases rapidly immediately adjacent to the single aperture as fluid infiltrates locally, which in turn dramatically slows the rate of subsequent fluid flow into the area. In contrast, the multiple apertures formed along the length of the cannula as described in the present invention, distribute the fluid throughout a much larger volume tissue before there can be a sufficient increase in the interstitial fluid to decrease the rate of additional infiltration. Further more, it is common practice to infiltrate the tumescent fluid into the subcutaneous space under augmented external pressure provided by an external peristaltic pump specifically designed for tumescent infiltration. By way of example and not limitation, a preferred suitable peristaltic infiltration pump is described in pending U.S. patent application Ser. No. 10/811,733, filed Mar. 29, 2004, entitled INFILTRATION PUMP HAVING INSULATED ROLLERS AND PROGRAMMABLE FOOT PEDAL, the disclosure of which is expressly incorporated herein by reference.
- The peristaltic pump provides a sufficient degree of pressure to easily overcome the localized increased interstitial pressure associated with the local effects of a tumescent infiltration. On the other hand, in situations where a peristaltic infiltration pump is not available, such as in remote locations without any available electrical power, the present invention still permits relatively rapid tumescent infiltration by virtue of the multiple holes distributed along the length of the flexible cannula. Furthermore, external hydrostatic pressure can be applied to the fluid flowing into the flexible cannula from the fluid reservoir by means of gravitational force derived from elevating the reservoir one to two meters above the patient. When using gravity to augment the flow of tumescent fluid, the infiltration process can be continuous or intermittent. In exemplary embodiments, the intermittent injections are administered at intervals ranging from every few minutes to eight to twelve hours or more.
- With the tumescent technique for local anesthesia, a large volume of dilute solution of local anesthesia and epinephrine is injected into the subcutaneous space resulting in a large bolus (or reservoir) of solution. The profound vasoconstrictive effect (shrinking of the capillaries) caused by the dilute epinephrine, produces a dramatic delay in the systemic absorption of the local anesthetic, which prolongs the anesthetic effects of tumescent anesthesia for eight to sixteen times longer than traditional techniques.
- Referring now to the drawings wherein the showings are for purposes of illustrating preferred embodiments of the present invention only, and not for purposes of limiting the same,
FIGS. 1 and 2 illustrate a stainless steel (reusable)infiltration cannula 10 andFIGS. 3-4 and 6-7 illustrate a (single use)plastic infiltration cannula 30. Thecannula skin 52 and into thesubcutaneous tissue 50 and tumescent local anesthesia can be infiltrated once every eight to twelve hours. - Stainless steel infiltration cannulas 10, such as the one shown in
FIGS. 1 and 2 , are formed having precision high quality and are preferably reusable. These cannulas can be used to provide tumescent local anesthesia for surgical procedures, such as liposuction, which require tumescent local anesthesia over a relatively large area. - The
cannula 10 includes atubular needle portion 12 which has aproximal end 14 and adistal end 16. Theproximal end 14 of thetubular needle 12 is attached to ahub 20 that is used by the anesthesiologist or surgeon to grasp and hold thecannula 10 during the infiltration procedure. Thehub 20 is connected to thetubular needle 12 at afirst end 22 and has aconnector 24, such as a luer lock, at an opposing second end. Theconnector 24 is connected to a fluid source, such as tubing connected to an IV bag. Fluid enters thecannula 10 via theconnector 24. - In exemplary embodiments, the tip at the
distal end 16 is closed. The local anesthetic is infiltrated into the patient viaapertures 18 located proximate thedistal end 16 of thetubular needle 12 of thecannula 10. In exemplary embodiments, theapertures 18 are disposed along thedistal end 16 of thecannula 10 in a spiral or helical pattern and are distributed over the distal 33% to 90% of thetubular needle 12 of thecannula 10. For example, if the length of the tubular needle D is 15 cm and theapertures 18 at thedistal end 16 cover a length d1 of 5 cm, the pattern of apertures of thecannula 10 are preferably distributed over 33% of thetubular needle 12 of thecannula 10. - The
proximal portion 14 of thecannula 10 is preferably devoid of apertures in order to prevent fluid from leaking out of the cannula insertion site in the skin. - Flexible
plastic infiltration cannulas 30, such as the one shown inFIGS. 3, 4 , 6 and 7 are single use cannulas and can be used in one of several unique ways. First, an anesthesiologist or surgeon can insert aninfiltration cannula 30 withstylet 46 into thesubcutaneous tissue 50, remove thestylet 46, then attach an IV tubing to the infiltrator and inject tumescent local anesthesia into the targeted area without subsequent repositioning of theinfiltration cannula 30. The plastic flexible nature of theinfiltration cannula 32 of the disposableplastic cannula 30 allows the patient to move or change position of the body without risk of injury that might result if a patient moves while a rigid steel cannula is inserted. - Preferably, the
stylet 46 is formed of metal, e.g., stainless steel, or of a rigid plastic material. Theplastic cannula 30 can be blunt-tipped with themetal stylet tip 48 covered by the roundedtip 39 of theplastic cannula 30. Alternatively, theplastic cannula 30 can be open-ended with thestylet 46 extending a short distance past theend 39 of theplastic cannula 30 as shown inFIG. 6 . In the case of the open ended cannula, thestylet 46 can be either blunt-tipped (seeFIG. 6 ; requiring a skin incision to permit insertion into the subcutaneous space), or sharp-tipped (seeFIG. 7 ; permitting the cannula to be inserted directly through the skin and into the subcutaneous space or muscle without requiring a preparatory skin incision). The sharp-tipped stylet can be formed in either a solid or hollow cross-sectional configuration. - The plastic cannula shown in
FIGS. 3 and 4 is similar to an IV catheter except the sharp hollow stylet used for the insertion of an IV catheter can be replaced by a solid obturator/stylet 46 that can be either sharp or blunt tipped. Except for theremovable stylet 46, theplastic cannula 30 is similar to thestainless steel cannula 10 shown inFIGS. 1 and 2 and described above. Theplastic cannula 30 includes a flexibletubular needle 32 having aproximal end 34 and adistal end 36. The distal end hasapertures 38 and theproximal end 34 is devoid of apertures. As stated above, in exemplary embodiments, the pattern ofapertures 38 in thecannula 30 are distributed over the distal 33% to 90% of thetubular needle 32 of thecannula 30. For example, if thetubular needle 32 ofcannula 30 shown inFIGS. 3 and 4 has a length D of 15 cm and the pattern of apertures are distributed over a length d1 of 13.5 cm, then theapertures 38 are distributed over 90% of the cannula. - A
typical infiltration cannula small apertures - The
proximal end 34 of thetubular needle 32 shown inFIGS. 3 and 4 is attached to ahub 40 that is used by the anesthesiologist or surgeon to hold thecannula 30 during the infiltration procedure. Thehub 40 is connected to thetubular needle 32 at afirst end 42 and has aconnector 44 at an opposing second end. Theconnector 44 is connected to a fluid source. As described above and shown inFIG. 4 , thestylet 46 can be inserted and removed from thecannula 30. - Infiltration using a
plastic infiltration cannula 30, such as the one shown inFIGS. 3 and 4 , can be accomplished using an infiltration pump. Alternatively, the force of gravity could be used to push the tumescent fluid into the tissues by hanging a reservoir plastic bag of tumescent local anesthesia (or other dilute drug, such as a chemotherapeutic agent or antibiotics) on an IV pole and connecting bag to the infiltration cannula by an IV line. - Another application is the injection of tumescent local anesthesia into a localized area through which a surgeon plans to make a surgical incision. The effects of vasoconstriction, resulting from the epinephrine in the tumescent local anesthetic solution, within the tumesced tissue minimizes surgical bleeding. In a uniquely preemptive fashion, the present invention can produce, via the pre-operative infiltration of tumescent local anesthesia, prolonged post operative analgesia and also preemptively reduce the risk of surgical wound infections resulting from the bacteriacidal effects of lidocaine.
- Yet another application is to provide an easily accessible route for systemic administration of crystalloid fluids/electrolytes for systemic hydration or for other types of drug therapy. Potential clinical applications include emergency resuscitation with systemic fluids in situations where insertion of an IV catheter into a vein cannot be readily achieved. Examples of situations where emergency access for intravenous delivery of fluids might not be possible include acute trauma or burn wound in civilian or military situations. Another application may be the emergency treatment of dehydration associated with prolonged vomiting or diarrhea as a result of chemical warfare or biological warfare (e.g., epidemic cholera among pediatric patients in rural third world settings). A subcutaneous infiltration catheter can easily be introduced by a layman, whereas inserting an IV catheter into a vein of a patient that is severely dehydrated can be difficult even for a skilled physician. Delivery of systemic fluids by subcutaneous infiltration is safer in a zero gravity situation (for example, the Space Station). The addition of a small amount of capillary vasodilator (e.g., methylnicotinamide) to the subcutaneous fluid can be used to accelerate the systemic absorption of the fluid or drug into the intravascular space. Further applicational uses for the present invention are described in co-pending application serial number unknown, filed concurrently herewith entitled DRUG DELIVERY SYSTEM FOR ACCELLERATED SUBCUTANEOUS ABSORPTION, the disclosure of which is expressly incorporated herein by reference.
- The
cannula skin 52 so that all of theapertures cannula - After one portion of the targeted area has been tumesced, the infiltration is briefly terminated (either by turning off the pump or by clamping the IV tubing) while the
cannula - The
infiltrator cannula cannula subcutaneous tissue 50. - Another unique aspect of the tumescent technique's reservoir effect is that one can conveniently achieve a long, slow, steady absorption of a drug delivered to the
subcutaneous space 50 using periodic injections of a tumescent solution. In certain situations, using a slow IV infusion, the alternative technique, can achieve a slow systemic absorption of a drug but may be difficult, require greater clinical expertise, be more expensive, and therefore, less practical than the technique described herein. -
FIG. 5 is a flow diagram illustrating steps performed in an exemplary infiltration procedure using acannula FIGS. 1 and 2 or the one shown inFIGS. 3 and 4 , respectively. The procedure begins by inserting thetubular needle infiltration cannula subcutaneous tissue site 50, e.g., via an incision in the patient's skin 52 (block 100). Fluid is then transported from the fluid source (e.g., an IV bag) into thecannula connector connector hub tubular needle 12, 32 (block 102). The fluid is then ejected from thecannula subcutaneous tissue 50 of the patient via theapertures distal end tubular needle cannula 10, 30 (block 104). - The fluid is transported (block 102) and ejected (block 104) until infiltration at the current site is completed (yes in decision block 106). The fluid can be injected into multiple sites in order to distribute the solution over a greater area.
- Infiltration at a particular site may be deemed complete upon emptying of the fluid source or based on the anesthesiologist or surgeon's decision to stop the infiltration at the current site. After one portion of the targeted area has been tumesced, the infiltration can be briefly terminated (either by turning off the pump or by clamping the IV tubing) while the
cannula - If infiltration is complete at the current site (yes in decision block 106) but infiltration is not complete (no in decision block 110), the
tubular needle infiltration cannula subcutaneous tissue 50. The process described above is performed until the infiltration process is complete (yes in decision block 110). This process can be continuous or repeated intermittently. - As described above, multiple infiltration cannulas (e.g., can be used at once). Thus, a second or additional cannulas can be inserted (block 100) at the same time as a first cannula is being removed (block 108). Thus, the infiltration process need not be interrupted in order to reposition a single cannula.
- Additional modifications and improvements of the present invention may also be apparent to those of ordinary skill in the art. Thus, the particular combination of parts described and illustrated herein is intended to represent only a certain embodiment of the present invention, and is not intended to serve as a limitation of alternative devices within the spirit and scope of the invention.
Claims (15)
1. An infiltration cannula for delivering a multi liter amount of fluid to a patient during an infiltration procedure, the infiltration cannula comprising:
a rigid stylet;
a flexible tubular cannula with the rigid stylet disposed within the flexible tubular cannula, the flexible tubular cannula comprising:
a proximal portion;
a distal portion defining a distal end, the distal end being open with a hole, and a tip of the rigid stylet protruding through the hole; and
a plurality of apertures disposed in a pattern about the distal portion, the apertures configured to infiltrate the multi-liter amount of fluid into subcutaneous tissue or muscle of a patient;
a hub configured to be held by a person performing the infiltration procedure, the hub having a first end and an opposing second end, the first end being attached to the proximal portion of the flexible tubular cannula, the second end comprising a connector for receiving the fluid to be infiltrated into the subcutaneous tissue of the patient, the fluid flowing from the connector, through the hub and into the flexible tubular cannula; and
a continuous flow pump connected to the connector of the hub and operative to continuously deliver fluid through the hub and the flexible tubular cannula at least until a large reservoir of fluid is infiltrated into the patient at a desired site of the patient.
2. The infiltration cannula as recited in claim 1 , wherein the tip of the rigid stylet protruding out of the hole is sharp to directly insert the cannula and the stylet through the skin of the patient without a prepatory skin incision.
3. The infiltration cannula as recited in claim 2 , wherein the apertures are distributed over about 33% to about 90% of the distal end of the flexible tubular cannula.
4. The infiltration cannula as recited in claim 1 , wherein the tip of the rigid stylet protruding out of the hole is blunt such that a prepatory skin incision is required to permit insertion of the stylet and flexible tubular cannula through the skin of the patient.
5. The infiltration cannula as recited in claim 4 , wherein the apertures are distributed over about 33% to about 90% of the distal end of the tubular needle.
6. A method of infiltrating a multi-liter amount of fluid into subcutaneous tissue of a patient, the method comprising:
a) inserting a rigid stylet within an open ended flexible tubular cannula until a tip of the rigid stylet protrudes from the open end;
b) inserting the flexible tubular cannula with the rigid stylet disposed therewithin through a patient's skin and into the subcutaneous tissue of the patient at a desired site;
c) removing the stylet from the flexible tubular cannula; and
d) continuously flowing the fluid through the flexible tubular cannula and into the patient via apertures formed along a distal portion of the flexible tubular cannula at least until a large reservoir of fluid has been infiltrated into the patient at the desired site.
7. The method of claim 6 wherein the tip of the stylet protruding out of the hole is blunt, and the method further comprises the step of making a prepatory skin incision prior to the inserting the flexible tubular cannula step b).
8. The method of claim 6 wherein the tip of the stylet protruding out of the hole is sharp, and the inserting the flexible tubular cannula step b) is accomplished without making a prepatory skin incision.
9. The method recited in claim 6 , further comprising inserting the flexible infiltration cannula at a new site in the patient's skin.
10. The method recited in claim 6 , wherein at least two flexible infiltration cannulas are inserted into the patient's skin to prevent disruption of the method when one flexible infiltration cannula is removed.
11. The method recited in claim 6 , wherein the continuously flowing step includes the step of continuously flowing a local anesthesia fluid.
12. The method recited in claim 6 , wherein the method is performed in conjunction with a surgical procedure or therapeutic drug delivery.
13. The method recited in claim 6 , wherein the apertures formed on the distal portion of the flexible tubular cannula are distributed about 33% to about 90% of the distal portion of the flexible tubular cannula, and the method further comprises the step of positioning the flexible tubular cannula within the patient until all of the apertures are within the patient and maintaining the flexible tubular cannula in the position until at least a portion of the multi-liter amount of fluid is infiltrated into the patient.
14. The cannula as recited in claim 1 , wherein the apertures are arranged in a helical pattern.
15. The cannula as recited in claim 1 , wherein the apertures are arranged in a spiral pattern.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/004,778 US20080108971A1 (en) | 2003-05-21 | 2007-12-21 | Infiltration cannula |
US13/176,870 US8512292B2 (en) | 2003-05-21 | 2011-07-06 | Infiltration cannula |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/442,370 US20040236307A1 (en) | 2003-05-21 | 2003-05-21 | Infiltration cannula |
US10/877,566 US20040236313A1 (en) | 2003-05-21 | 2004-06-25 | Infiltration cannula |
US12/004,778 US20080108971A1 (en) | 2003-05-21 | 2007-12-21 | Infiltration cannula |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/877,566 Division US20040236313A1 (en) | 2003-05-21 | 2004-06-25 | Infiltration cannula |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/176,870 Continuation US8512292B2 (en) | 2003-05-21 | 2011-07-06 | Infiltration cannula |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080108971A1 true US20080108971A1 (en) | 2008-05-08 |
Family
ID=38479891
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/877,566 Abandoned US20040236313A1 (en) | 2003-05-21 | 2004-06-25 | Infiltration cannula |
US12/004,778 Abandoned US20080108971A1 (en) | 2003-05-21 | 2007-12-21 | Infiltration cannula |
US13/176,870 Expired - Lifetime US8512292B2 (en) | 2003-05-21 | 2011-07-06 | Infiltration cannula |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/877,566 Abandoned US20040236313A1 (en) | 2003-05-21 | 2004-06-25 | Infiltration cannula |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/176,870 Expired - Lifetime US8512292B2 (en) | 2003-05-21 | 2011-07-06 | Infiltration cannula |
Country Status (1)
Country | Link |
---|---|
US (3) | US20040236313A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100080826A1 (en) * | 2008-09-26 | 2010-04-01 | Salubrious Pharmaceuticals LLC | Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers |
US20100330117A1 (en) * | 2008-09-26 | 2010-12-30 | Salubrious Pharmaceutical, Llc | Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c |
WO2011019884A2 (en) * | 2009-08-12 | 2011-02-17 | Global Vein Solutions, Llc | Tumescent anesthesia delivery in conjunction with endovenous vein therapy |
WO2011066577A1 (en) * | 2009-11-30 | 2011-06-03 | Jeffrey Alan Klein | Tumescent antibiotic solution |
US20120130415A1 (en) * | 2010-11-15 | 2012-05-24 | Vascular Insights Llc | Vascular treatment device |
US20140142497A1 (en) * | 2012-08-13 | 2014-05-22 | Michael Esposito | Bowed tip for laparoscopic surgery |
WO2018148434A1 (en) * | 2017-02-08 | 2018-08-16 | Veran Medical Technologies, Inc. | Localization needle |
US10463388B2 (en) | 2006-09-13 | 2019-11-05 | Merit Medical Systems, Inc. | Wire and device for vascular treatment |
US11213481B2 (en) | 2004-06-25 | 2022-01-04 | Hk Pharma | Tumescent drug delivery |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL128261A0 (en) | 1999-01-27 | 1999-11-30 | Disc O Tech Medical Tech Ltd | Expandable element |
US7621950B1 (en) | 1999-01-27 | 2009-11-24 | Kyphon Sarl | Expandable intervertebral spacer |
EP2311408B1 (en) | 2003-03-14 | 2019-02-20 | DePuy Spine, Inc. | Hydraulic device for injection of bone cement in percutaneous vertebroplasty |
US8066713B2 (en) | 2003-03-31 | 2011-11-29 | Depuy Spine, Inc. | Remotely-activated vertebroplasty injection device |
US20040236313A1 (en) | 2003-05-21 | 2004-11-25 | Klein Jeffrey A. | Infiltration cannula |
US20040236307A1 (en) * | 2003-05-21 | 2004-11-25 | Klein Jeffrey A. | Infiltration cannula |
US8105310B2 (en) | 2003-05-21 | 2012-01-31 | Klein Jeffrey A | Infiltration cannula |
US8415407B2 (en) | 2004-03-21 | 2013-04-09 | Depuy Spine, Inc. | Methods, materials, and apparatus for treating bone and other tissue |
WO2005030034A2 (en) | 2003-09-26 | 2005-04-07 | Depuy Spine, Inc. | Device for delivering viscous material |
CA2575699C (en) | 2004-07-30 | 2014-07-08 | Disc-O-Tech Medical Technologies Ltd. | Methods, materials and apparatus for treating bone and other tissue |
US9381024B2 (en) | 2005-07-31 | 2016-07-05 | DePuy Synthes Products, Inc. | Marked tools |
US9918767B2 (en) | 2005-08-01 | 2018-03-20 | DePuy Synthes Products, Inc. | Temperature control system |
US20070106245A1 (en) * | 2005-11-08 | 2007-05-10 | Kerberos Proximal Solutions, Inc. | Infusion guidewire |
US8360629B2 (en) | 2005-11-22 | 2013-01-29 | Depuy Spine, Inc. | Mixing apparatus having central and planetary mixing elements |
US9289232B2 (en) * | 2006-05-05 | 2016-03-22 | Avent, Inc. | Soft tissue tunneling device |
US9642932B2 (en) | 2006-09-14 | 2017-05-09 | DePuy Synthes Products, Inc. | Bone cement and methods of use thereof |
EP3095511A1 (en) | 2006-10-19 | 2016-11-23 | Depuy Spine Inc. | Sealed container |
US8241266B2 (en) * | 2007-04-05 | 2012-08-14 | Entellus Medical, Inc. | Apparatus and method for treatment of ethmoids |
WO2011130639A1 (en) | 2010-04-15 | 2011-10-20 | Entellus Medical, Inc. | Method and apparatus for treating dilating the ethmoid infundibulum |
EP2609952B1 (en) * | 2011-12-30 | 2015-01-14 | Q-Med AB | Bruiseless cannula |
FR3012041B1 (en) * | 2013-10-23 | 2016-09-02 | Sebastien Besse | INJECTION NEEDLE |
US10493024B2 (en) * | 2015-10-12 | 2019-12-03 | Hk Tumescent Pharma Corporation | Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity |
Citations (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2708437A (en) * | 1952-03-31 | 1955-05-17 | Elizabeth Painter Hutchins | Surgical instrument |
US3082805A (en) * | 1960-12-21 | 1963-03-26 | John H Royce | Tissue macerator |
US3732858A (en) * | 1968-09-16 | 1973-05-15 | Surgical Design Corp | Apparatus for removing blood clots, cataracts and other objects from the eye |
US3764099A (en) * | 1972-03-02 | 1973-10-09 | A Parduhn | Signal mastarm bracket |
US3955579A (en) * | 1973-07-23 | 1976-05-11 | Henry Bridgman | Vacuum curet |
US3994297A (en) * | 1974-12-09 | 1976-11-30 | Kopf J David | Ophthalmic instrument |
US4167944A (en) * | 1977-06-27 | 1979-09-18 | Surgical Design Corp. | Rotatable surgical cutting instrument with improved cutter blade wear |
US4203444A (en) * | 1977-11-07 | 1980-05-20 | Dyonics, Inc. | Surgical instrument suitable for closed surgery such as of the knee |
US4311140A (en) * | 1976-05-10 | 1982-01-19 | Henry Bridgman | Vacuum curet having an improved curetting opening |
US4314560A (en) * | 1979-11-28 | 1982-02-09 | Helfgott Maxwell A | Powered handpiece for endophthalmic surgery |
US4405322A (en) * | 1981-12-23 | 1983-09-20 | The Kendall Company | Anesthesia device |
US4460360A (en) * | 1982-08-30 | 1984-07-17 | Finegold Aaron N | Urethral anesthetic devices |
US4487600A (en) * | 1981-11-09 | 1984-12-11 | Brownlie Alan W | Adjustable suction device for medical use |
US4530656A (en) * | 1979-06-29 | 1985-07-23 | Ruhrgas Aktiengesellschaft | Burner |
US4536180A (en) * | 1983-07-22 | 1985-08-20 | Johnson Gerald W | Surgical instrument for suction lipolysis |
US4577629A (en) * | 1983-10-28 | 1986-03-25 | Coopervision, Inc. | Surgical cutting instrument for ophthalmic surgery |
US4586921A (en) * | 1983-08-17 | 1986-05-06 | Daniel Berson | Method of applying a local anesthetic agent to a wound |
US4589414A (en) * | 1983-04-27 | 1986-05-20 | Olympus Optical Co., Ltd. | Surgical cutting instrument |
US4713053A (en) * | 1984-05-07 | 1987-12-15 | Hans Lee | Method and apparatus for performing suction lipectomy |
US4735605A (en) * | 1986-09-15 | 1988-04-05 | Swartz Barry E | Lipectomy device having round cutting edges |
US4775365A (en) * | 1986-09-15 | 1988-10-04 | Barry Swartz | Lipectomy cannula |
US4784649A (en) * | 1987-03-20 | 1988-11-15 | The Cooper Companies, Inc. | Surgical aspirator cannula |
US4790830A (en) * | 1985-04-01 | 1988-12-13 | Hamacher Edward N | Infusion needle |
US4815462A (en) * | 1987-04-06 | 1989-03-28 | Clark Vickie J | Lipectomy device |
US4850354A (en) * | 1987-08-13 | 1989-07-25 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US4886491A (en) * | 1988-02-29 | 1989-12-12 | Tulio Parisi | Liposuction procedure with ultrasonic probe |
US4919129A (en) * | 1987-11-30 | 1990-04-24 | Celebration Medical Products, Inc. | Extendable electrocautery surgery apparatus and method |
US4925450A (en) * | 1987-03-20 | 1990-05-15 | The Cooper Companies, Inc. | Surgical aspirator cannula |
US4932935A (en) * | 1986-09-15 | 1990-06-12 | Barry Swartz | Assisted lipectomy device |
US4938743A (en) * | 1984-05-07 | 1990-07-03 | Hans Lee | Surgical apparatus for performing suction lipectomy |
US5052999A (en) * | 1990-01-29 | 1991-10-01 | Klein Jeffrey A | Liposuction method and apparatus |
US5112302A (en) * | 1990-07-16 | 1992-05-12 | Cucin Robert L | Method and apparatus for performing liposuction |
US5186714A (en) * | 1992-05-18 | 1993-02-16 | Yab Revo-Tech Inc. | Multifunctional surgical instrument |
US5447493A (en) * | 1994-01-10 | 1995-09-05 | Very Inventive Physicians, Inc. | Tumescent lipoplastic apparatus |
US5655544A (en) * | 1995-03-30 | 1997-08-12 | Johnson; Gerald W. | Endoscopic assisted abdominoplasty |
US5800407A (en) * | 1995-12-21 | 1998-09-01 | Eldor; Joseph | Multiple hole epidural catheter |
US5817050A (en) * | 1997-05-29 | 1998-10-06 | Klein; Jeffrey A. | Liposuction cannula |
US6071260A (en) * | 1997-09-18 | 2000-06-06 | The California Institute Of Tissue Engineering And Instrumentation, Llc | Ultrasonic liposuction device and a method of using the same |
US6162202A (en) * | 1998-10-26 | 2000-12-19 | Sicurelli; Robert | Flexible syringe needle |
US6280424B1 (en) * | 1999-12-21 | 2001-08-28 | Ethicon, Inc. | Apparatus and method for using a needle in an intravascular assembly |
US6375648B1 (en) * | 1998-10-02 | 2002-04-23 | Misonix Incorporated | Infiltration cannula with teflon coated outer surface |
US20020123723A1 (en) * | 2001-03-02 | 2002-09-05 | Sorenson James Levoy | Apparatus and method for specific interstitial or subcutaneous diffusion and dispersion of medication |
US20030144628A1 (en) * | 2000-12-19 | 2003-07-31 | Laksen Sirimanne | Percutaneous catheter assembly |
US6613026B1 (en) * | 1999-12-08 | 2003-09-02 | Scimed Life Systems, Inc. | Lateral needle-less injection apparatus and method |
US6685666B1 (en) * | 1999-11-12 | 2004-02-03 | Mark G. Fontenot | Catheters for breast surgery |
US6692473B2 (en) * | 2001-05-24 | 2004-02-17 | John A. St. Cyr | Dual lumen adjustable length cannulae for liquid perfusion or lavage |
US6916292B2 (en) * | 2002-07-12 | 2005-07-12 | Depuy Spine, Inc. | Bone marrow aspirator |
US6969373B2 (en) * | 2001-04-13 | 2005-11-29 | Tricardia, Llc | Syringe system |
US7056315B2 (en) * | 2001-11-07 | 2006-06-06 | Eschmann Holdings Limited | Liposuction apparatus with pressurized liquid spray and liposuction method using the apparatus |
US7465291B2 (en) * | 1999-07-19 | 2008-12-16 | I-Flow Corporation | Method of fluid delivery and catheters for use with same |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3734099A (en) | 1971-04-07 | 1973-05-22 | H Bender | Powered surgical cutter |
US4448760A (en) * | 1982-09-30 | 1984-05-15 | Chemetals Incorporated | Continuous process for the preparation of manganite, MnOOH |
US4530356A (en) * | 1983-02-08 | 1985-07-23 | Helfgott Maxwell A | Ophthalmic surgical instrument with beveled tip |
US5314407A (en) * | 1986-11-14 | 1994-05-24 | Heart Technology, Inc. | Clinically practical rotational angioplasty system |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5295980A (en) * | 1989-10-30 | 1994-03-22 | Ersek Robert A | Multi-use cannula system |
US5203769A (en) * | 1989-11-06 | 1993-04-20 | Mectra Labs, Inc. | Medical device valving mechanism |
US5181907A (en) * | 1990-03-20 | 1993-01-26 | Hilton Becker | Cannula and method for liposuction |
US5643198A (en) * | 1990-12-14 | 1997-07-01 | Rocin Laboratories, Inc. | Power-assisted liposuction instrument and cannula assembly therefor |
US5348535A (en) * | 1990-12-14 | 1994-09-20 | Rocin Laboratories, Inc. | Power-assisted liposuction instrument and cannula assembly therefor |
JPH0611308B2 (en) * | 1991-04-19 | 1994-02-16 | 克弥 高須 | Liposuction device and its equipment |
JPH0611309B2 (en) * | 1991-05-28 | 1994-02-16 | 克弥 高須 | Collagen collection device |
US5342194A (en) * | 1992-06-03 | 1994-08-30 | Feldman Richard L | Dental imaging matrix band for making or setting crowns and bridges on prepared teeth |
US5352194A (en) | 1992-06-29 | 1994-10-04 | University Of Pittsburgh | Automated device for liposuction |
US5242386A (en) * | 1992-08-27 | 1993-09-07 | Sontech Limited | Echographic suction cannula |
US5286253A (en) * | 1992-10-09 | 1994-02-15 | Linvatec Corporation | Angled rotating surgical instrument |
NL9300626A (en) * | 1993-04-13 | 1994-11-01 | Cordis Europ | Hydrodynamic suction catheter. |
US5472416A (en) * | 1994-01-10 | 1995-12-05 | Very Inventive Physicians, Inc. | Tumescent lipoplastic method and apparatus |
US5489291A (en) * | 1994-02-23 | 1996-02-06 | Wiley; Roy C. | Apparatus for removing tissue during surgical procedures |
US5514086A (en) * | 1994-09-22 | 1996-05-07 | Sonique Surgical Systems, Inc. | Multipiece ultrasonic probe for liposuction |
AU6268396A (en) * | 1995-06-02 | 1996-12-18 | Surgical Design Corporation | Phacoemulsification handpiece, sleeve, and tip |
US6113569A (en) * | 1995-12-21 | 2000-09-05 | Very Inventive Physicians | Reciprocating liposuction device |
US5807282A (en) * | 1995-12-28 | 1998-09-15 | Mayo Foundation For Medical Education And Research | Endometrial tissue curette and method |
US6020196A (en) * | 1996-05-09 | 2000-02-01 | Baxter International Inc. | Devices for harvesting and homogenizing adipose tissue containing autologous endothelial cells |
US6102885A (en) * | 1996-08-08 | 2000-08-15 | Bass; Lawrence S. | Device for suction-assisted lipectomy and method of using same |
US6706026B1 (en) | 1996-08-09 | 2004-03-16 | Cook Urological Incorporated | Instillation uterine catheter |
US5766194A (en) * | 1996-12-23 | 1998-06-16 | Georgia Skin And Cancer Clinic, Pc | Surgical apparatus for tissue removal |
US5884631A (en) * | 1997-04-17 | 1999-03-23 | Silberg; Barry | Body contouring technique and apparatus |
US5968008A (en) * | 1997-08-04 | 1999-10-19 | Grams; Guenter A. | Cannula with parallel channels and sliding sheath |
US6436116B1 (en) * | 1997-10-06 | 2002-08-20 | Smith & Nephew, Inc. | Methods and apparatus for removing veins |
DE19806693A1 (en) * | 1998-02-18 | 1999-08-19 | Daum Gmbh | Telescopically working needle and tube system for removal of tumor |
US6039048A (en) * | 1998-04-08 | 2000-03-21 | Silberg; Barry | External ultrasound treatment of connective tissue |
FR2777462A1 (en) | 1998-04-20 | 1999-10-22 | Jean Luc Morel | Cannula for infiltration, aspiration or evacuation of living tissues, especially adipose fat |
US6129701A (en) * | 1998-11-19 | 2000-10-10 | Sound Surgical Technologies, Llc | Vented aspirator and method |
US6524300B2 (en) | 2000-01-03 | 2003-02-25 | Angiodynamics, Inc. | Infusion catheter with non-uniform drug delivery density |
US6503263B2 (en) * | 2000-09-24 | 2003-01-07 | Medtronic, Inc. | Surgical micro-shaving instrument with elevator tip |
US20040215143A1 (en) | 2003-01-13 | 2004-10-28 | Martin Brady | Hollow stylet for infusion catheter systems, devices and methods |
US20040236313A1 (en) | 2003-05-21 | 2004-11-25 | Klein Jeffrey A. | Infiltration cannula |
US7542808B1 (en) | 2004-09-17 | 2009-06-02 | Cardiac Pacemakers, Inc. | Lead and catheter assembly |
-
2004
- 2004-06-25 US US10/877,566 patent/US20040236313A1/en not_active Abandoned
-
2007
- 2007-12-21 US US12/004,778 patent/US20080108971A1/en not_active Abandoned
-
2011
- 2011-07-06 US US13/176,870 patent/US8512292B2/en not_active Expired - Lifetime
Patent Citations (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2708437A (en) * | 1952-03-31 | 1955-05-17 | Elizabeth Painter Hutchins | Surgical instrument |
US3082805A (en) * | 1960-12-21 | 1963-03-26 | John H Royce | Tissue macerator |
US3732858A (en) * | 1968-09-16 | 1973-05-15 | Surgical Design Corp | Apparatus for removing blood clots, cataracts and other objects from the eye |
US3764099A (en) * | 1972-03-02 | 1973-10-09 | A Parduhn | Signal mastarm bracket |
US3955579A (en) * | 1973-07-23 | 1976-05-11 | Henry Bridgman | Vacuum curet |
US3994297A (en) * | 1974-12-09 | 1976-11-30 | Kopf J David | Ophthalmic instrument |
US4311140A (en) * | 1976-05-10 | 1982-01-19 | Henry Bridgman | Vacuum curet having an improved curetting opening |
US4167944A (en) * | 1977-06-27 | 1979-09-18 | Surgical Design Corp. | Rotatable surgical cutting instrument with improved cutter blade wear |
US4203444A (en) * | 1977-11-07 | 1980-05-20 | Dyonics, Inc. | Surgical instrument suitable for closed surgery such as of the knee |
US4203444B1 (en) * | 1977-11-07 | 1987-07-21 | ||
US4530656A (en) * | 1979-06-29 | 1985-07-23 | Ruhrgas Aktiengesellschaft | Burner |
US4314560A (en) * | 1979-11-28 | 1982-02-09 | Helfgott Maxwell A | Powered handpiece for endophthalmic surgery |
US4487600A (en) * | 1981-11-09 | 1984-12-11 | Brownlie Alan W | Adjustable suction device for medical use |
US4405322A (en) * | 1981-12-23 | 1983-09-20 | The Kendall Company | Anesthesia device |
US4460360A (en) * | 1982-08-30 | 1984-07-17 | Finegold Aaron N | Urethral anesthetic devices |
US4589414A (en) * | 1983-04-27 | 1986-05-20 | Olympus Optical Co., Ltd. | Surgical cutting instrument |
US4536180A (en) * | 1983-07-22 | 1985-08-20 | Johnson Gerald W | Surgical instrument for suction lipolysis |
US4586921A (en) * | 1983-08-17 | 1986-05-06 | Daniel Berson | Method of applying a local anesthetic agent to a wound |
US4577629A (en) * | 1983-10-28 | 1986-03-25 | Coopervision, Inc. | Surgical cutting instrument for ophthalmic surgery |
US4713053A (en) * | 1984-05-07 | 1987-12-15 | Hans Lee | Method and apparatus for performing suction lipectomy |
US4938743A (en) * | 1984-05-07 | 1990-07-03 | Hans Lee | Surgical apparatus for performing suction lipectomy |
US4790830A (en) * | 1985-04-01 | 1988-12-13 | Hamacher Edward N | Infusion needle |
US4735605A (en) * | 1986-09-15 | 1988-04-05 | Swartz Barry E | Lipectomy device having round cutting edges |
US4775365A (en) * | 1986-09-15 | 1988-10-04 | Barry Swartz | Lipectomy cannula |
US4932935A (en) * | 1986-09-15 | 1990-06-12 | Barry Swartz | Assisted lipectomy device |
US4784649A (en) * | 1987-03-20 | 1988-11-15 | The Cooper Companies, Inc. | Surgical aspirator cannula |
US4925450A (en) * | 1987-03-20 | 1990-05-15 | The Cooper Companies, Inc. | Surgical aspirator cannula |
US4815462A (en) * | 1987-04-06 | 1989-03-28 | Clark Vickie J | Lipectomy device |
US4850354A (en) * | 1987-08-13 | 1989-07-25 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US4919129A (en) * | 1987-11-30 | 1990-04-24 | Celebration Medical Products, Inc. | Extendable electrocautery surgery apparatus and method |
US4886491A (en) * | 1988-02-29 | 1989-12-12 | Tulio Parisi | Liposuction procedure with ultrasonic probe |
US5052999A (en) * | 1990-01-29 | 1991-10-01 | Klein Jeffrey A | Liposuction method and apparatus |
US5112302A (en) * | 1990-07-16 | 1992-05-12 | Cucin Robert L | Method and apparatus for performing liposuction |
US5186714A (en) * | 1992-05-18 | 1993-02-16 | Yab Revo-Tech Inc. | Multifunctional surgical instrument |
US5447493A (en) * | 1994-01-10 | 1995-09-05 | Very Inventive Physicians, Inc. | Tumescent lipoplastic apparatus |
US5655544A (en) * | 1995-03-30 | 1997-08-12 | Johnson; Gerald W. | Endoscopic assisted abdominoplasty |
US5800407A (en) * | 1995-12-21 | 1998-09-01 | Eldor; Joseph | Multiple hole epidural catheter |
US5817050A (en) * | 1997-05-29 | 1998-10-06 | Klein; Jeffrey A. | Liposuction cannula |
US6071260A (en) * | 1997-09-18 | 2000-06-06 | The California Institute Of Tissue Engineering And Instrumentation, Llc | Ultrasonic liposuction device and a method of using the same |
US6428499B1 (en) * | 1997-09-18 | 2002-08-06 | California Institute Of Tissue Engineering And Instrumentation, Llc | Ultrasonic liposuction device and method of using the same |
US6375648B1 (en) * | 1998-10-02 | 2002-04-23 | Misonix Incorporated | Infiltration cannula with teflon coated outer surface |
US6162202A (en) * | 1998-10-26 | 2000-12-19 | Sicurelli; Robert | Flexible syringe needle |
US7465291B2 (en) * | 1999-07-19 | 2008-12-16 | I-Flow Corporation | Method of fluid delivery and catheters for use with same |
US6685666B1 (en) * | 1999-11-12 | 2004-02-03 | Mark G. Fontenot | Catheters for breast surgery |
US6613026B1 (en) * | 1999-12-08 | 2003-09-02 | Scimed Life Systems, Inc. | Lateral needle-less injection apparatus and method |
US6280424B1 (en) * | 1999-12-21 | 2001-08-28 | Ethicon, Inc. | Apparatus and method for using a needle in an intravascular assembly |
US20030144628A1 (en) * | 2000-12-19 | 2003-07-31 | Laksen Sirimanne | Percutaneous catheter assembly |
US20020123723A1 (en) * | 2001-03-02 | 2002-09-05 | Sorenson James Levoy | Apparatus and method for specific interstitial or subcutaneous diffusion and dispersion of medication |
US6969373B2 (en) * | 2001-04-13 | 2005-11-29 | Tricardia, Llc | Syringe system |
US6692473B2 (en) * | 2001-05-24 | 2004-02-17 | John A. St. Cyr | Dual lumen adjustable length cannulae for liquid perfusion or lavage |
US7056315B2 (en) * | 2001-11-07 | 2006-06-06 | Eschmann Holdings Limited | Liposuction apparatus with pressurized liquid spray and liposuction method using the apparatus |
US6916292B2 (en) * | 2002-07-12 | 2005-07-12 | Depuy Spine, Inc. | Bone marrow aspirator |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9623030B2 (en) | 2004-06-25 | 2017-04-18 | Jeffrey Alan KLEIN | Tumescent antibiotic solution |
US11213481B2 (en) | 2004-06-25 | 2022-01-04 | Hk Pharma | Tumescent drug delivery |
US10322083B2 (en) | 2004-06-25 | 2019-06-18 | Hk Pharma | Tumescent drug delivery |
US11903608B2 (en) | 2006-09-13 | 2024-02-20 | Merit Medical Systems, Inc. | Wire and device for vascular treatment |
US10463388B2 (en) | 2006-09-13 | 2019-11-05 | Merit Medical Systems, Inc. | Wire and device for vascular treatment |
US20100330117A1 (en) * | 2008-09-26 | 2010-12-30 | Salubrious Pharmaceutical, Llc | Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c |
US20100080826A1 (en) * | 2008-09-26 | 2010-04-01 | Salubrious Pharmaceuticals LLC | Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers |
US20110020392A1 (en) * | 2008-10-14 | 2011-01-27 | Salubrious Pharmaceutical, Llc | Process for treatment of rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers |
WO2010123524A1 (en) * | 2009-04-20 | 2010-10-28 | Salubrious Pharmaceuticals LLC | Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers |
WO2011019884A2 (en) * | 2009-08-12 | 2011-02-17 | Global Vein Solutions, Llc | Tumescent anesthesia delivery in conjunction with endovenous vein therapy |
WO2011019884A3 (en) * | 2009-08-12 | 2011-07-21 | Global Vein Solutions, Llc | Tumescent anesthesia delivery in conjunction with endovenous vein therapy |
US20120265168A1 (en) * | 2009-08-12 | 2012-10-18 | Horowitz John D | Tumescent anesthesia delivery in connection with endovenous vein therapy |
WO2011066577A1 (en) * | 2009-11-30 | 2011-06-03 | Jeffrey Alan Klein | Tumescent antibiotic solution |
US8957060B2 (en) | 2009-11-30 | 2015-02-17 | Jeffrey Alan KLEIN | Tumescent antibiotic solution |
CN102781509A (en) * | 2009-11-30 | 2012-11-14 | 杰弗里·艾伦·克莱因 | Tumescent antibiotic solution |
US9585667B2 (en) * | 2010-11-15 | 2017-03-07 | Vascular Insights Llc | Sclerotherapy catheter with lumen having wire rotated by motor and simultaneous withdrawal from vein |
US11241250B2 (en) | 2010-11-15 | 2022-02-08 | Merit Medical Systems, Inc. | Vascular treatment devices and methods |
US20120130415A1 (en) * | 2010-11-15 | 2012-05-24 | Vascular Insights Llc | Vascular treatment device |
US20140142497A1 (en) * | 2012-08-13 | 2014-05-22 | Michael Esposito | Bowed tip for laparoscopic surgery |
WO2018148434A1 (en) * | 2017-02-08 | 2018-08-16 | Veran Medical Technologies, Inc. | Localization needle |
US11439742B2 (en) | 2017-02-08 | 2022-09-13 | Veran Medical Technologies, Inc. | Localization needle |
Also Published As
Publication number | Publication date |
---|---|
US20040236313A1 (en) | 2004-11-25 |
US8512292B2 (en) | 2013-08-20 |
US20110282271A1 (en) | 2011-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8512292B2 (en) | Infiltration cannula | |
US8246587B2 (en) | Infiltration cannula | |
US8529541B2 (en) | Infiltration cannula | |
JP4604022B2 (en) | Portable device for the administration of fluids to tissues and tumors by a delivery-enhanced delivery method | |
JP2519873B2 (en) | A catheter / needle assembly and kit for injecting therapeutic agents into the subarachnoid cavity | |
US5234406A (en) | Method and system for continuous spinal delivery of anesthetics | |
US7232425B2 (en) | Apparatus and method for specific interstitial or subcutaneous diffusion and dispersion of medication | |
ES2250437T3 (en) | INTRADERMAL ADMINISTRATION OF SUBSTANCES. | |
US5997524A (en) | Catheter assembly for percutaneous access to subcutaneous port | |
US7351246B2 (en) | Minimally invasive, sustained, intra-tympanic drug delivery system | |
ES2854002T3 (en) | Conical diffuser tip | |
US5989239A (en) | Method and apparatus for percutaneously accessing an implanted port | |
AU2009202335B2 (en) | Pulsatile flux drug delivery | |
CN103002934A (en) | Tissue infusion apparatus and method | |
Rosenfeld et al. | Epidural morphine treatment of pain in Guillain-Barré syndrome | |
WO2001091830A1 (en) | Implantable fluid delivery system | |
Ingemar et al. | Epidural administration of opiates by a new device | |
CN206518584U (en) | The minimally invasive micro Mutiple Targets injecting systems of intracerebral for stereotaxis navigation equipment | |
Moore et al. | Continuous saphenous nerve block for total knee arthroplasty: when and how? | |
JPS62112568A (en) | Catheter for administering fluid to local part of human body | |
US20230355894A1 (en) | Multi-slot injection needle | |
CN112569457B (en) | Continuous administration cyst tube system | |
WO2023181979A1 (en) | Therapeutic device for brain diseases, connector for therapeutic devices, and connector fixing tool for therapeutic devices | |
CN200998472Y (en) | Postoperative regional anesthesia analgesia bag | |
Pickup | Clinical applications of infusion systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |